Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
02/03/2011 | US20110027276 Optimized CD40 Antibodies and Methods of Using the Same |
02/03/2011 | US20110027268 Anti-mesothelin antibodies and uses thereof |
02/03/2011 | US20110027267 Fusion Proteins of Mannose Binding Lectins for Treatment of Disease |
02/03/2011 | US20110027266 Humanized anti-CXCR5 antibodies, derivatives thereof and their use |
02/03/2011 | US20110027258 Modified vitamin k-dependent polypeptides |
02/03/2011 | US20110027256 Fusion proteins |
02/03/2011 | US20110027252 Variants of An Alpha-Amylase with Improved Production Levels in Fermentation Processes |
02/03/2011 | US20110027249 Fusion of Peptidoglycan Hydrolase Enzymes to a Protein Transduction Domain Allows Eradication of both Extracellular and Intracellular Gram Positive Pathogens |
02/03/2011 | US20110027240 Secretable hiv entry inhibitory peptides for therapy of hiv infection |
02/03/2011 | US20110027234 Methods for identification and selection of human embryonic stem cell derived cells |
02/03/2011 | US20110027218 Tnf superfamily fusion proteins |
02/03/2011 | US20110027183 Hydrophobic Modified Pres-Derived Peptides of Hepatitis B Virus (HBV) and Their Use as Vehicles for the Specific Delivery of Compounds to the Liver |
02/03/2011 | US20110027173 Ephrin type-a receptor 10 protein |
02/03/2011 | DE102009035671A1 Verfahren zur Expression von homologen Proteinen und/oder Peptiden in Pilzen der Klasse Dothideomycetes Method for the expression of homologous proteins and / or peptides in fungi of the class Dothideomycetes |
02/03/2011 | CA2772049A1 Wd repeat 79 protein targeted therapy |
02/03/2011 | CA2771850A1 Method for purifying active gla-domain coagulation proteins |
02/03/2011 | CA2771835A1 Method for purifying gla-domain coagulation proteins |
02/03/2011 | CA2769752A1 Adenoviral-based vectors |
02/03/2011 | CA2769745A1 Widespread gene delivery to the retina using systemic administration of aav vectors |
02/03/2011 | CA2769673A1 Reverse genetics systems |
02/03/2011 | CA2769670A1 Rna with a combination of unmodified and modified nucleotides for protein expression |
02/03/2011 | CA2769643A1 Axmi-192 family of pesticidal genes and methods for their use |
02/03/2011 | CA2769618A1 Combination of a chemotherapeutic agent and an inhibitor of the tgf-beta system |
02/03/2011 | CA2769558A1 Mutants of pyrroloquinoline quinine-dependent soluble glucose dehydrogenase |
02/03/2011 | CA2769538A1 Oligonucleotides inhibiting cellular migration |
02/03/2011 | CA2769518A1 Dual variable domain immunoglobulins and uses thereof |
02/03/2011 | CA2769456A1 Methods and compositions for identifying and validating modulators of cell fate |
02/03/2011 | CA2769420A1 Proteases with modified pre-pro regions |
02/03/2011 | CA2769311A1 Barley and uses thereof |
02/03/2011 | CA2769258A1 Modified factor ix polypeptides and uses thereof |
02/03/2011 | CA2769257A1 Improved human long pentraxin 3 expression system and uses thereof |
02/03/2011 | CA2768997A1 High yield yellow fever virus strain with increased propagation in cells |
02/03/2011 | CA2768887A1 Orf7 deficient varicella virus, vaccine comprising the virus and use thereof |
02/03/2011 | CA2767976A1 Cell-targeting nanoparticles comprising polynucleotide agents and uses thereof |
02/03/2011 | CA2767962A1 Mutant methylglyoxal synthase (mgs) for the production of a biochemical by fermentation |
02/02/2011 | EP2280494A2 Method and apparatus for data transmission using multiple transmit antennas |
02/02/2011 | EP2280083A1 Nucleid acid ligand diagnostic biochip |
02/02/2011 | EP2280082A2 Identification of surface-associated antigenes used for the diagnosis and therapy of tumours |
02/02/2011 | EP2280078A1 Marker for determination of breast cancer, test method, and test kit |
02/02/2011 | EP2280077A1 Method for detection of cancer cell induced by hpv, method for determination concerning whether or not tissue is in later stage of severe dysplasia, and primer set and kit for use in the methods |
02/02/2011 | EP2280076A1 Method for expressing homologous proteins and/or peptides in dothideomycetes fungi |
02/02/2011 | EP2280074A2 Polynucleotides encoding antigenic HIV type B and/or type C polypeptides, polypeptides and uses thereof |
02/02/2011 | EP2280073A2 Vaccine for prevention and treatment of HIV-infection |
02/02/2011 | EP2280072A2 Group B streptococcus antigens |
02/02/2011 | EP2280071A2 Haemophilus influenzae antigens and corresponding DNA fragments |
02/02/2011 | EP2280070A1 Methods and compositions for RNAi mediated inhibition of gene expression in mammals |
02/02/2011 | EP2280069A1 A method of detecting and/or quantifying expression of a target protein candidate in a cell, and a method of identifying a target protein of a small molecule modulator |
02/02/2011 | EP2280068A1 Novel aldolase and production process of substituted alpha-keto acids |
02/02/2011 | EP2280067A2 Novel genes encoding novel proteolytic enzymes |
02/02/2011 | EP2280066A2 Recombinant Clostridium neurotoxin fragments |
02/02/2011 | EP2280063A1 Pichia pastoris as a host for the production of the ribosome-inactivating protein (RIP) saporin and saporin fusion chimaeras |
02/02/2011 | EP2280031A1 Cancer antigens based on products of the tumor suppressor gene WT1 |
02/02/2011 | EP2280030A2 Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers |
02/02/2011 | EP2280019A1 Antisense modulation of C-reactive protein expression |
02/02/2011 | EP2279757A2 Compounds for targeting endothelial cells |
02/02/2011 | EP2279755A2 Remodelling and glycoconjugation of Fibroblast Growth Factor (FGF) |
02/02/2011 | EP2279754A2 Remodelling and glycoconjugation of human growth hormone (hGH) |
02/02/2011 | EP2279753A2 Remodeling and glycoconjugation of peptides |
02/02/2011 | EP2279747A1 Immunogenic bacterial vesicles with outer membrane proteins |
02/02/2011 | EP2279444A1 System and method for micromanipulating samples |
02/02/2011 | EP2279271A2 Gene expression profiling based identification of genomic signature of high-risk multiple myeloma and uses thereof |
02/02/2011 | EP2279254A1 Novel lipid formulations for nucleic acid delivery |
02/02/2011 | EP2279252A2 Use of rice polypeptides/nucleic acids for plant improvement |
02/02/2011 | EP2279251A2 Isoprene synthase variants for improved microbial production of isoprene |
02/02/2011 | EP2279242A2 Engineering of xylose reductase and overexpression of xylitol dehydrogenase and xylulokinase improves xylose alcoholic fermentation in the thermotolerant yeast hansenula polymorpha |
02/02/2011 | EP2279241A2 Development of strains of the thermotolerant yeast hansenula polymorpha capable of alcoholic fermentation of starch and xylan by expression of starch and xylan degrading enzymes |
02/02/2011 | EP2279205A1 Modified stefin a scaffold proteins |
02/02/2011 | EP2279203A2 Prion epitopes and methods of use thereof |
02/02/2011 | EP2279202A1 Multimeric forms of antimicrobial peptides |
02/02/2011 | EP2027276B1 Antifungal polypeptides |
02/02/2011 | EP1996708B1 Recombinant mononegaviral virus vectors |
02/02/2011 | EP1815001B1 Gene trap cassettes for random and targeted conditional gene inactivation |
02/02/2011 | EP1766026B1 Glucose isomerase mutants |
02/02/2011 | EP1747274B9 Preparation method for the production of active and soluble proteins in prokaryotes and polycistronic vectors therefor |
02/02/2011 | EP1594971B1 Transposon-based targeting system |
02/02/2011 | EP1539976B1 Method for producing biodegradable, functionalised polymer particles, and use of the same as medicament carriers |
02/02/2011 | EP1481068B1 A method of selectively producing male or female sterile plants |
02/02/2011 | EP1447448B1 Novel n-acetylglucosamine transferase, nucleic acid encoding the same, antibody against the same and use thereof for diagnosing cancer or tumor |
02/02/2011 | EP1391506B1 Animal with gene hypoexpression |
02/02/2011 | EP1364212B1 Three hybrid assay system |
02/02/2011 | EP1301532B1 Plant cyclin-dependent kinase inhibitors |
02/02/2011 | EP1013763B1 Canine interleukin 18 production method |
02/02/2011 | CN1970573B Neutrality monoclonal antibody 3E1 for resisting ricin, its preparation method and uses |
02/02/2011 | CN1930277B Method for producing polyunsaturated fatty acids in transgenic plants |
02/02/2011 | CN1894405B Arachidonic acid-containing plant and utilization of the same |
02/02/2011 | CN1863915B Lambda integrase mediated recombination in plants |
02/02/2011 | CN1844387B Antisense oligonucleotide structure inhibiting Sirt1 gene expression and use thereof |
02/02/2011 | CN1764474B Immunogenic composition and methods |
02/02/2011 | CN101965405A Plants having enhanced yield-related traits and a method for making the same |
02/02/2011 | CN101965404A Novel bacillus thuringiensis gene with coleopteran activity |
02/02/2011 | CN101965403A Composition for neutralizing botulinus toxin type-a, and human anti-botulinus toxin type-a antibody |
02/02/2011 | CN101965402A Engineered hybird phage vectors for the design and the generation of a human non-antibody peptide or protein phage library via fusion to pix of m13 phage |
02/02/2011 | CN101965401A A pentose sugar fermenting cell |
02/02/2011 | CN101965400A A pentose sugar fermenting cell |
02/02/2011 | CN101965396A Recombinant vaccinia virus having hepatitis c virus gene |
02/02/2011 | CN101965365A Antibody capable of combining the soluble ass oligomer specifically and application thereof |
02/02/2011 | CN101965360A Novel bacillus thuringiensis gene with coleopteran activity |
02/02/2011 | CN101965359A Novel bacillus thuringiensis gene with coleopteran activity |
02/02/2011 | CN101965196A Sugar chain-related gene and use thereof |
02/02/2011 | CN101962693A Real-time fluorescence quantitation PCR (Polymerase Chain Reaction) detection method of monkey vacuolating virus and kit |